183 related articles for article (PubMed ID: 18768525)
1. No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.
Qiu W; Zhou G; Zhai Y; Zhang X; Xie W; Zhang H; Yang H; Zhi L; Yuan X; Zhang X; He F
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2514-8. PubMed ID: 18768525
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
[TBL] [Abstract][Full Text] [Related]
3. The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients.
Okamoto K; Mandai M; Mimura K; Murawaki Y; Yuasa I
Res Commun Mol Pathol Pharmacol; 2005; 117-118():77-89. PubMed ID: 18426080
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S
Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk.
Zhai Y; Qiu W; Dong XJ; Zhang XM; Xie WM; Zhang HX; Yuan XY; Zhou GQ; He FC
Gut; 2007 Mar; 56(3):445-7. PubMed ID: 17339256
[No Abstract] [Full Text] [Related]
7. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
[TBL] [Abstract][Full Text] [Related]
8. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
Chen X; Wang H; Xie W; Liang R; Wei Z; Zhi L; Zhang X; Hao B; Zhong S; Zhou G; Zhang L; Gao X; Zhu Y; He F
Pharmacogenet Genomics; 2006 Mar; 16(3):219-27. PubMed ID: 16495781
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic polymorphisms in STAT1 gene with increased risk of hepatocellular carcinoma.
Zhu ZZ; Di JZ; Gu WY; Cong WM; Gawron A; Wang Y; Zheng Q; Wang AZ; Zhu G; Zhang P; Hou L
Oncology; 2010; 78(5-6):382-8. PubMed ID: 20798561
[TBL] [Abstract][Full Text] [Related]
10. MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.
Wu LM; Zhang F; Xie HY; Xu X; Chen QX; Yin SY; Liu XC; Zhou L; Xu XB; Sun YL; Zheng SS
Clin Genet; 2008 Mar; 73(3):273-8. PubMed ID: 18177474
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
Shan K; Lian-Fu Z; Hui D; Wei G; Na W; Xia J; Yan L
Mol Hum Reprod; 2006 Jan; 12(1):35-9. PubMed ID: 16455621
[TBL] [Abstract][Full Text] [Related]
12. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH
Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
[TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
[TBL] [Abstract][Full Text] [Related]
15. Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers.
Dong X; Zhou G; Zhai Y; Zhang H; Yang H; Zhi L; Zhang X; Chu J; He F
Cancer Epidemiol; 2009 Oct; 33(3-4):265-70. PubMed ID: 19766077
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
Román-García P; Coto E; Reguero JR; Cannata-Andía JB; Lozano I; Avanzas P; Morís C; Rodríguez I
Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856
[TBL] [Abstract][Full Text] [Related]
17. Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
Tang Y; Zhu J; Chen L; Chen L; Zhang S; Lin J
Clin Cancer Res; 2008 May; 14(9):2870-7. PubMed ID: 18451255
[TBL] [Abstract][Full Text] [Related]
18. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
[TBL] [Abstract][Full Text] [Related]
19. The Contribution of
Shen TC; Hsia TC; Chao CY; Chen WC; Chen CY; Chen WC; Lin YT; Hsiao CL; Chang WS; Tsai CW; Bau DT
Anticancer Res; 2017 Jul; 37(7):3563-3567. PubMed ID: 28668847
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.
Yuan X; Zhou G; Zhai Y; Xie W; Cui Y; Cao J; Zhi L; Zhang H; Yang H; Zhang X; Qiu W; Peng Y; Zhang X; Yu L; Xia X; He F
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3621-7. PubMed ID: 19064581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
